Healthcare M&A Seminar

May. 26, 2021 - May. 27, 2021

About This Event

Covid-19 has had a profound impact on the way healthcare providers deliver care to patients. As a result of the pandemic, healthcare providers have been financially challenged as they have been forced to focus their efforts away from elective procedures and, instead, to treating Covid patients. Innovative services such as telemedicine, virtual care and remote patient monitoring have all disrupted the market, creating new strategic opportunities for dealmakers.

It is more critical than ever for Healthcare dealmakers to focus their attention current opportunities and pitfalls and keep pace with the latest developments in the M&A market.

Join The Deal and a roster of senior corporate executives, private equity and institutional investors, and corporate advisers for The Deal’s Healthcare M&A Seminar. This virtual event features two days of online sessions exploring the current state of Healthcare M&A and the opportunities, obstacles and risks dealmakers face, and how to navigate through them. Your registration provides access to all of the sessions. View them live as they happen or on demand at a time that is convenient for you.

Speakers

Thomas M. Moriarty
Executive Vice President, Chief Policy and External Affairs Officer, and General Counsel, CVS Health

Thomas M. Moriarty is an accomplished business strategy, legal and policy executive who has held leadership positions at some of the largest and most innovative health care companies in the country.

Read Bio
Brad Armstrong
Partner, Lovell Minnick
Read Bio
Andrew Bab
Partner, Debevoise & Plimpton
Read Bio
Ge Bai
Associate Professor of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health
Read Bio
Christian Chauvet
Principal, Lee Equity Partners
Read Bio
Carl Culicchia
Principal, SV Health Investors
Read Bio
Benjamin Daverman
Managing Director, GTCR
Read Bio
Matthew Evans
Managing Director & Head of Healthcare Finance, Monroe Capital
Read Bio
Adam Feinstein
Managing Partner, Vesey Street Capital Partners
Read Bio
Michael Fisher
Partner, Varsity Healthcare Partners
Read Bio
Alexis Gilman
Partner, Crowell & Mooring
Read Bio
Andrew Kaplan
Principal, Bain Capital, Private Equity
Read Bio
Mike Kaplan
Advisory Partner, Granite Growth Health Partners
Read Bio
Erin Lansky
Vice President, Blue Sea Capital
Read Bio
Gregg Michaelson
Partner, Edison Partners
Read Bio
Wilfried Piskula
Managing Director, Eurazeo
Read Bio
Todd Rosenberg
Partner, Crowell & Mooring
Read Bio
Todd Rudsenske
Partner, Webster Equity Partners
Read Bio
Gregory Schernecke
Partner, Dechert
Read Bio
Alissa Walker
Senior Associate, LorientCapital
Read Bio

Agenda

Wednesday, May 26, 2021
10:00am – 11:00am Eastern
The State of Healthcare M&A: What’s Driving Strategic Partnership Transactions?

The new environment of the healthcare market continues to create new strategic and business opportunities as a result of the Covid-19 pandemic. Healthcare providers have been prompted to shift their priorities to maintain stability during the crisis, creating openings for disruptors offering innovative services such as telemedicine, virtual care and remote patient monitoring. What are the likely near-term and longer-term drivers behind healthcare M&A and strategic partnership transactions? What has the shift done to valuations, and what type of deal structures are we seeing? How do dealmakers continue to find innovative companies and get capital to those that need it most?

Panelist: Adam Feinstein, Managing Partner, Vesey Street Capital Partners

Panelist: Geoff Lieberthal, Partner, Torquest Partners

Panelist: Todd Rosenberg, Partner, Crowell & Mooring

11:00am – 11:30am eastern
Networking Break
11:30am – 12:30pm Eastern
Healthcare Technology: How Disruptive Technologies are Changing the Market

The digital health sector has experienced massive growth with the adoption of remote monitoring, telehealth and telemedicine services causing enormous disruptive changes in the market. Will the industry finally see advances in highly scalable machine learning and artificial intelligence solutions? Many experts feel that a shift to cloud-based EHR platforms that enable providers to access patient data anywhere, and communication and collaboration tools have strong potential for growth. What’s next for the digital health sector, and how are disruptive technologies changing the landscape of deals?

Panelist: Carl Culicchia, Principal, SV Health Investors

Panelist: Ezra Mehlman, Managing Partner, Health Enterprise Partners

Panelist: Gregg Michaelson, Partner, Edison Partners

Panelist: Wilfried Piskula, Managing Director, Eurazeo

12:30pm – 1:30pm Eastern
Lunch
1:30pm – 2:30pm Eastern
Exploring Behavioral Health M&A

The COVID-19 pandemic has had a profound impact on the way we live and work and with it comes uncertainty, altered daily routines, financial pressures and social isolation. In addition to the medial worries related to the virus, there is a drastic increase in mental health issues including depression, substance abuse, anxiety and suicide. The healthcare market is seeing a continued increase in demand for mental health services. This panel will explore how behavioral health M&A has become one of the most sought-after sectors in healthcare services and will examine the opportunities available for investors and innovative companies in the space.

Panelist: Christian Chauvet, Principal, Lee Equity Partners

Panelist: Matthew Evans, Managing Director & Head of Healthcare Finance, Monroe Capital

Panelist: Michael Fisher, Partner, Varsity Healthcare Partners

Panelist: Mike Kaplan, Advisory Partner, Granite Growth Health Partners

Panelist: Erin Lansky, Vice President, Blue Sea Capital

Panelist: Todd Rudsenske, Partner, Webster Equity Partners

2:30pm – 3:00pm Eastern
Networking Break
3:00pm – 3:30pm Eastern
Keynote Interview with Thomas Moriarty, Executive Vice President, Chief Policy and External Affairs Officer, and General Counsel, CVS Health

Speaker: Thomas Moriarty, Executive Vice President, Chief Policy and External Affairs Officer, and General Counsel, CVS Health

3:45pm – 4:45pm Eastern
Navigating Healthcare and Pharma Deals Under the Biden Administration

With the shift in power in Washington and the ongoing pandemic, healthcare and pharmaceutical M&A is in the spotlight. There are strong indications that transactions in the sector could draw closer scrutiny from the Biden administration, potentially resulting in more conditions and legal challenges. How should investors and corporates navigate this terrain? Which types of health-related transactions would be welcomed by the antitrust agencies, and what sorts of combinations are most likely to face turbulence? Would significant mergers raise more antitrust problems than acquisitions of startups, or would both face heightened risk? If mergers are presented as accelerating breakthroughs, such as vaccines, are they more likely to be allowed to proceed? The Covid-19 public health crisis also is a key variable for dealmakers. Are companies reshaping negotiations, delaying closings, and altering strategies as the pandemic impacts the merger process?

Panelist: Alexis Gilman, Partner, Crowell & Mooring

Thursday, May 27, 2021
10:00am – 11:00am Eastern
Is Big Tech Poised to Further Disrupt Healthcare?

Amazon, Google, Apple and Facebook have a track record of disrupting major industries. Amazon acquired PillPack and Health Navigator and last year launched Amazon Pharmacy. The Apple Watch doubles as a virtual healthcare assistant, and their platform called Apple ResearchKit provides a platform for medical research. Alphabet’s moves in the health space include the purchase of Senosis Health, an app developer focused on using smartphone sensors as monitoring devices, and Google’s acquisition of wearable device company Fitbit. This panel will delve into the strides taken by the tech giants in the healthcare space and what they might mean for the deal landscape.

Panelist: Ge Bai, Associate Professor of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health

11:00am – 11:30am Eastern
Networking Break
11:30am – 12:30pm Eastern
Private Equity Update: Where are Investors Seeing Opportunity?

Private Equity has record amounts of capital that needs to be deployed, but valuations and pricing are being severely affected by current market volatility. Dealmakers continue to be more cautious and selective, but buyers are looking to take advantage of opportunistic acquisitions. What businesses are seeing increased attention from healthcare private equity investors? How will the recovery effect pricing, valuations and risk allocation? This panel of dealmakers will share their perspective on the current state of private equity healthcare investing.

Moderator: Gregory Schernecke, Partner, Dechert

Panelist: Brad Armstrong, Partner, Lovell Minnick

Panelist: Benjamin Daverman, Managing Director, GTCR

Panelist: Andrew Kaplan, Principal, Bain Capital, Private Equity

Panelist: Alissa Walker, Senior Associate, LorientCapital

12:30pm – 1:30pm Eastern
Lunch
1:30pm – 2:30pm Eastern
SPACs: An Alternative Route to the Public Market

Special Purpose Acquisition Companies (SPACs), also known as blank-check companies, have been around for the last 20 years or so, but have seen a recent resurgence as the market deals with high levels of liquidity, depressed valuations and a strong appetite for growth companies. SPACs raise money in an IPO and place it in a trust while the sponsor looks for a target to acquire. Once the companies complete the merger, the target company becomes a listed stock. What are the challenges that surround these transactions, and how are SPACs different from typical M&A transactions? Are their trends in Healthcare SPAC M&A that dealmakers need to be aware of?

Panelist: Andrew Bab, Partner, Debevoise & Plimpton

2:30pm – 3:00pm Eastern
Networking Break
3:00pm – 3:30pm Eastern
Spotlight Session
3:45pm – 4:45pm Eastern
Is M&A a Necessity for Independent Health Systems?

Much of the financial hardship that hospitals and health systems are facing comes from reductions in elective procedures due to the Covid-19 pandemic. With many health systems preoccupied with managing the financial and operational struggles caused by the pandemic, M&A activity was down in 2020. Will we see a surge in pent-up M&A activity as independent hospitals and smaller systems explore partnerships in order to ensure the continued delivery of quality healthcare to the organizations’ communities? What opportunities does this present for both small and large health systems and investors?

Virtual Event Features

View the How To Guide or watch the How To Video.

Speaker interaction
Reach out to speakers taking part in their live Q&A after their session

 

Personal Program
Create your own schedule with meetings and interesting sessions

 

On-Demand Access
Watch at a more convenient time to suit your needs

 

Virtual Exhibition Hall
Meet sponsors at their virtual booths

 

Messaging and Video calls
Meeting someone new? Drop them a message or schedule a call

 

AI Powered Matchmaking
Meet new people in the event with AI recommendations

Sponsors

Contact Us

Fill out the form to reach our team regarding your inquiries related to Registration, Sales/Sponsorship, Speaking, and Press. You can also subscribe to the Events Newsletter to keep up-to-date with The Deal Events.

More Upcoming Events

Apr
26
Awards

The Deal Awards 2021

The Deal will recognize the deals and dealmakers shaping the Deal Economy.

Apr
28
Corporate Governance

Corporate Sustainability Seminar

Explore how companies are creating more sustainable businesses and the implications of the Biden Administration’s pledge to make climate change a top priority.